Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.
Ciccone M, Agostinelli C, Rigolin GM, Piccaluga PP, Cavazzini F, Righi S, Sista MT, Sofritti O, Rizzotto L, Sabattini E, Fioritoni G, Falorio S, Stelitano C, Olivieri A, Attolico I, Brugiatelli M, Zinzani PL, Saccenti E, Capello D, Negrini M, Cuneo A, Pileri S. Ciccone M, et al. Among authors: rizzotto l. Leukemia. 2012 Mar;26(3):499-508. doi: 10.1038/leu.2011.247. Epub 2011 Sep 23. Leukemia. 2012. PMID: 21941366
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.
Ferracin M, Zagatti B, Rizzotto L, Cavazzini F, Veronese A, Ciccone M, Saccenti E, Lupini L, Grilli A, De Angeli C, Negrini M, Cuneo A. Ferracin M, et al. Among authors: rizzotto l. Mol Cancer. 2010 May 26;9:123. doi: 10.1186/1476-4598-9-123. Mol Cancer. 2010. PMID: 20504344 Free PMC article. Clinical Trial.
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.
Cavazzini F, Rizzotto L, Sofritti O, Daghia G, Cibien F, Martinelli S, Ciccone M, Saccenti E, Dabusti M, Elkareem AA, Bardi A, Tammiso E, Cuneo A, Rigolin GM. Cavazzini F, et al. Among authors: rizzotto l. Leuk Lymphoma. 2012 Jan;53(1):83-8. doi: 10.3109/10428194.2011.606384. Epub 2011 Sep 13. Leuk Lymphoma. 2012. PMID: 21767243
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters.
Rigolin GM, Cibien F, Martinelli S, Formigaro L, Rizzotto L, Tammiso E, Saccenti E, Bardi A, Cavazzini F, Ciccone M, Nichele I, Pizzolo G, Zaja F, Fanin R, Galieni P, Dalsass A, Mestichelli F, Testa N, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: rizzotto l. Blood. 2012 Mar 8;119(10):2310-3. doi: 10.1182/blood-2011-11-395269. Epub 2012 Jan 13. Blood. 2012. PMID: 22246039 Free article.
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia.
Maffei R, Fiorcari S, Bulgarelli J, Rizzotto L, Martinelli S, Rigolin GM, Debbia G, Castelli I, Bonacorsi G, Santachiara R, Forconi F, Rossi D, Laurenti L, Palumbo GA, Vallisa D, Cuneo A, Gaidano G, Luppi M, Marasca R. Maffei R, et al. Among authors: rizzotto l. Exp Hematol. 2014 Feb;42(2):126-36.e1. doi: 10.1016/j.exphem.2013.10.007. Epub 2013 Nov 6. Exp Hematol. 2014. PMID: 24212063 Free article. Clinical Trial.
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.
Rigolin GM, Saccenti E, Rizzotto L, Ferracin M, Martinelli S, Formigaro L, Cibien F, Cavallari M, Lista E, Daghia G, Sofritti O, Ciccone M, Cavazzini F, Lupini L, Bassi C, Zagatti B, Negrini M, Cuneo A. Rigolin GM, et al. Among authors: rizzotto l. Oncotarget. 2014 Jan 15;5(1):140-9. doi: 10.18632/oncotarget.1382. Oncotarget. 2014. PMID: 24334759 Free PMC article.
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide.
Maffei R, Fiorcari S, Martinelli S, Benatti S, Bulgarelli J, Rizzotto L, Debbia G, Santachiara R, Rigolin GM, Forconi F, Rossi D, Laurenti L, Palumbo GA, Vallisa D, Cuneo A, Gaidano G, Luppi M, Marasca R. Maffei R, et al. Among authors: rizzotto l. Leuk Lymphoma. 2018 Feb;59(2):423-433. doi: 10.1080/10428194.2017.1339872. Epub 2017 Jun 22. Leuk Lymphoma. 2018. PMID: 28639485 Clinical Trial.
Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma.
Bardi A, Cavazzini F, Rigolin GM, Tammiso E, Volta E, Pezzolo E, Formigaro L, Sofritti O, Daghia G, Ambrosio C, Rizzotto L, Abass AE, D'Auria F, Musto P, Cuneo A. Bardi A, et al. Among authors: rizzotto l. J Biomed Biotechnol. 2011;2011:691493. doi: 10.1155/2011/691493. Epub 2011 May 21. J Biomed Biotechnol. 2011. PMID: 21629757 Free PMC article.
42 results